EchoLaser and TPLA technique: successful procedures and international guests in Verona
On July 25th, 2025, at the Verona University Hospital (AOUI Verona), Professor Alessandro Antonelli and his team successfully performed three treatments for benign prostatic hyperplasia (BPH) and one focal therapy for prostate cancer using the EchoLaser system with...
EchoLaser TPLA at the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace (China)
Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious...
EchoLaser is now NMPA approved
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...
EchoLaser on Corriere della Sera
Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership. Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite. It is a novel technique which is...
Practical Theoretical Course at the LXY Institute in MADRID!
The theoretical - practical course at the LXY Institute in Madrid, where EchoLaser TPLA played a central role as a treatment for IPB, ended. Discover more thanks to Dr. Pablo Garrido Abad!...